Zoetis Inc. (ZTS): Navigating Headwinds, Betting on Long-Term Animal Health Leadership
Zoetis Inc. (ZTS), the global leader in animal health, faces near-term challenges linked to its osteoarthritis drug Librela. Despite a recent stock pullback, analysts point to the company's durable competitive moat, strong companion animal growth trends, and resilient livestock business as reasons for long-term optimism.